State of Connecticut v. GlaxoSmithKline LLC: The state of Connecticut is slated to receive nearly $1.7 million as part of a $90 million, 37-state settlement with the makers of the diabetes drug Avandia.
States Settle Claim Against Diabetes Drug Maker
The Connecticut Law Tribune
November 26, 2012
This article requires premium access
This article requires premium access to Connecticut Law Tribune. Please sign in or subscribe to read the full text.